(Q37809460)

23 August 2017

title

Monoclonal antibody therapy directed against human acute myeloid leukemia stem cells (English)

1 reference

23 August 2017

1 reference

1 reference

acute myeloid leukemia

0 references

1 reference

R Majeti

1

1 reference

23 August 2017

language of work or name

English

0 references

publication date

15 November 2010

1 reference

23 August 2017

1 reference

23 August 2017

volume

30

1 reference

23 August 2017

issue

9

1 reference

23 August 2017

page(s)

1009-1019

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2010.511

23 August 2017

exact match

0 references

cites work

C-type lectin-like molecule-1: a novel myeloid cell surface marker associated with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

The SIRP family of receptors and immune regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

Isolation of a candidate human hematopoietic stem-cell population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

CD47 (integrin-associated protein) engagement of dendritic cell and macrophage counterreceptors is required to prevent the clearance of donor lymphohematopoietic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

Integrin-associated protein (CD47) and its ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

Treatment of older patients with acute myeloid leukemia--new agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

Monoclonal Antibody Therapy for B-Cell Non-Hodgkin's Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

Expression of Thy-1 on human hematopoietic progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

Cancer stem cells: models and concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

Stem cell concepts renew cancer research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

21 January 2018

Acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

Detection of molecular targets on the surface of CD34+/CD38-- stem cells in various myeloid malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

The roles of FLT3 in hematopoiesis and leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

Analysis of factors that affect in vitro chemosensitivity of leukaemic stem and progenitor cells to gemtuzumab ozogamicin (Mylotarg) in acute myeloid leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

Targeting of CD44 eradicates human acute myeloid leukemic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

Monoclonal antibody-mediated targeting of CD123, IL-3 receptor alpha chain, eliminates human acute myeloid leukemic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

A cell initiating human acute myeloid leukaemia after transplantation into SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

Internal tandem duplications of the FLT3 gene are present in leukemia stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

21 January 2018

Acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

Identification of a hierarchy of multipotent hematopoietic progenitors in human cord blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

Negative regulation of phagocytosis in macrophages by the CD47-SHPS-1 system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

CD47-signal regulatory protein alpha (SIRPalpha) regulates Fcgamma and complement receptor-mediated phagocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

Role of CD47 as a marker of self on red blood cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

Efficient tumour formation by single human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

Stem cells, cancer, and cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

DNA vaccination induces WT1-specific T-cell responses with potential clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

Identification of therapeutic targets for quiescent, chemotherapy-resistant human leukemia stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

Humanized mice in translational biomedical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

Species- and cell type-specific interactions between CD47 and human SIRPalpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

The cancer stem cell hypothesis: a work in progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

Hematopoietic stem cells express multiple myeloid markers: implications for the origin and targeted therapy of acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34(-) fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

Interleukin-2 receptor alpha-chain (CD25) expression on leukaemic blasts is predictive for outcome and level of residual disease in AML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

Interleukin-3 receptor in acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

High stem cell frequency in acute myeloid leukemia at diagnosis predicts high minimal residual disease and poor survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

The novel AML stem cell associated antigen CLL-1 aids in discrimination between normal and leukemic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

Expression of interleukin-3 receptor subunits on defined subpopulations of acute myeloid leukemia blasts predicts the cytotoxicity of diphtheria toxin interleukin-3 fusion protein against malignant progenitors that engraft in immunodeficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

Targeting C-type lectin-like molecule-1 for antibody-mediated immunotherapy in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

Monoclonal antibody therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

Ligation of the CD44 adhesion molecule reverses blockage of differentiation in human acute myeloid leukemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

The molecular basis of leukemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

Tumor growth need not be driven by rare cancer stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

Gemtuzumab ozogamicin in the treatment of acute myeloid leukemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.511

31 March 2020

Identifiers

DOI

10.1038/ONC.2010.511

1 reference

23 August 2017

1 reference